MENU
+Compare
QURE
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$12.84
Change
-$0.12 (-0.93%)
Capitalization
685.87M

QURE uniQure NV Forecast, Technical & Fundamental Analysis

a company which engages in the discovery, development, and commercialization of gene therapies

Industry Biotechnology
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for QURE with price predictions
Feb 21, 2025

QURE in downward trend: price dove below 50-day moving average on February 10, 2025

QURE moved below its 50-day moving average on February 10, 2025 date and that indicates a change from an upward trend to a downward trend. In of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on QURE as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for QURE crossed bearishly below the 50-day moving average on February 14, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QURE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for QURE entered a downward trend on February 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where QURE's RSI Oscillator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where QURE advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

QURE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. QURE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.285) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). QURE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (21.739) is also within normal values, averaging (251.218).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QURE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

QURE is expected to report earnings to fall 26.10% to -67 cents per share on March 03

uniQure NV QURE Stock Earnings Reports
Q4'24
Est.
$-0.67
Q3'24
Beat
by $0.11
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.08
Q4'23
Missed
by $0.06
The last earnings report on November 05 showed earnings per share of -91 cents, beating the estimate of -101 cents. With 740.08K shares outstanding, the current market capitalization sits at 685.87M.
A.I. Advisor
published General Information

General Information

a company which engages in the discovery, development, and commercialization of gene therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Paasheuvelweg 25
Phone
+31 202406000
Employees
480
Web
https://www.uniqure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGICX17.26N/A
N/A
SGI US Large Cap Equity C
IVFLX3.87N/A
N/A
Federated Hermes Intl Strat Val Div R6
VENAX64.83N/A
N/A
Vanguard Energy Index Admiral
WIMVX11.54N/A
N/A
Segall Bryant & Hamill Glb All Cp Inst
LAVVX16.24N/A
N/A
Lord Abbett Fundamental Equity R6

QURE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with CMRX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
-0.93%
CMRX - QURE
57%
Loosely correlated
-0.39%
NAMS - QURE
49%
Loosely correlated
-2.26%
HOOK - QURE
44%
Loosely correlated
-1.66%
AXON - QURE
42%
Loosely correlated
-5.28%
SNGX - QURE
36%
Loosely correlated
-0.41%
More